Celesq® Programs

Celesq®-West IP Master Series: Appropriate Responses to Demand Letters in the Post-Seagate, Post-MedImmune Era

Program Number
Program Date

Our Celesq®-West IP Master Series continues. In this installment, Anthony F. Lo Cicero of Amster, Rothstein & Ebenstein discusses how the expansion of declaratory judgment jurisdiction after MedImune, and the emphasis on willfulness issues in the post-complaint environment after Seagate, have altered the way that companies can and should respond to patent demand letters.

Available in States

  • Arizona
  • California
  • Colorado Eligible
  • Georgia
  • Missouri
  • New Jersey Eligible
  • New York
  • Texas Self Study

Program Categories

  • California Participatory MCLE Programs
  • In-House Counsel
  • Intellectual Property Law
  • Litigation & Litigation Skills
  • New York Accredited